09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/
Related
Virginia Eatery Routinely Subjected Gay Male Server and His Straight Friend to Homophobic Taunts and...
Read More >
On February 26, 2020, the United States Supreme Court, in a unanimous decision by Justice Samuel Ali...
Read More >
The amendments will become effective on January 4, 2021, with earlier compliance permitted. The ame...
Read More >
California environmental agencies recently issued a draft vapor intrusion guidance document that wil...
Read More >
Our Virtual Regional Compliance Conferences provide updates on the latest news in regulatory require...
Read More >
The Creation of the Contract-Generation Measure Introduces New Incentives for Hiring - New Legislat...
Read More >